Investigating the role of glycogen in lung adenocarcinoma development
Official title: Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
Funded at University of Florida · NIH-10904804 · Data updated 2026-11-12
This study is looking at how glycogen affects the growth of lung adenocarcinoma, a common type of lung cancer, and aims to find new ways to understand and treat it better by using advanced imaging to see glycogen levels in lung tissues from patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $504,786 |
| NIH project number | 5R01CA266004-04 |
| Project ID | NIH-10904804 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with lung adenocarcinoma who are seeking new treatment options.
✕Less likely to help
Patients with other types of lung cancer, such as lung squamous cell carcinoma, may not benefit from this research.
What this research studies
This research focuses on lung adenocarcinoma, a common and deadly form of lung cancer, by exploring the role of glycogen in tumor growth. The team has developed advanced imaging technology to visualize glycogen levels in lung tissues with high precision. By analyzing samples from patients, they aim to identify specific glycogen characteristics that could lead to better understanding and treatment options for lung adenocarcinoma. The goal is to uncover molecular mechanisms that could pave the way for personalized therapies.
Why it matters
Potential benefit: If successful, this research could lead to new, targeted treatments for lung adenocarcinoma, improving survival rates and patient outcomes.
How similar studies have gone: Previous studies have shown promising results in understanding the role of glycogen in cancer, but this specific approach using advanced imaging technology is relatively novel.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Sun, Ramon C. — University of Florida
- Study coordinator: Sun, Ramon C.
Related research
Other NIH-funded projects on the same topics.
-
Understanding a highly flexible cell state in lung cancer that worsens outcomes
A doctor-scientist at Cedars-Sinai wants to learn how a highly adaptable lung cancer cell state drives disease progression and resistance to therapy, using models that resemble human tumors.
-
Breaking cytokine loops in LKB1-mutant lung cancer and the immune system
A researcher at NYU School of Medicine is studying why a common lung cancer subtype with a specific mutation doesn’t respond well to current immunotherapy, with the aim of finding new ways to improve treatment.
-
Lung Adenocarcinoma: From Genome Changes to New Therapies
This NIH grant supports research on lung adenocarcinoma to better understand its genome changes and translate that knowledge into better diagnosis and treatments for patients.
-
Understanding how lung cancer and immune cells influence each other in early lung cancer development
A study looks at how lung cells and immune cells change together as early lung cancer (lung adenocarcinoma) develops, with the goal of finding points to intervene early.
-
Targeting a cancer pathway to stop metastasis in SMARCA4-deficient lung cancer
This grant aims to understand and interrupt a key pathway that drives spread of a specific type of lung cancer in people whose tumors have SMARCA4 mutations.
-
Combining imaging and biopsy genes to spot aggressive vs. slow-growing early lung cancer before surgery
Aimed at people with early-stage lung adenocarcinoma, this project tests a combined imaging and biopsy gene‑marker approach to better predict tumor aggressiveness before surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.